PPHM news!! Peregrine Pharmaceuticals (NASDAQ:PPHM) said that it has received a letter from The NASDAQ Stock Market advising the firm that it has regained full compliance with the NASDAQ Capital Market’s minimum bid price continued listing requirement. The letter detailed that as of December 10th, Peregrine exhibited a closing bid price of its common stock above the $1 minimum requirement for at least ten consecutive trading days, thus regaining compliance with NASDAQ Marketplace Rule 5550A-2; consequently, the matter is closed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.